MELIO CENTER FOR REGENERATIVE MEDICINE – Trademark Portfolio

Entity Type: 03

MELIO CENTER FOR REGENERATIVE MEDICINE holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include BW and BODYWELLE. The owner is based in Miami Beach, FL.

2100 Park Ave, Suite 405S

Miami Beach, FL 33139

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BW
BW
Registered 2024
BODYWELLE
BODYWELLE
Registered 2024

Trademark Classifications

MELIO CENTER FOR REGENERATIVE MEDICINE's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does MELIO CENTER FOR REGENERATIVE MEDICINE have?

MELIO CENTER FOR REGENERATIVE MEDICINE has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MELIO CENTER FOR REGENERATIVE MEDICINE file in?

MELIO CENTER FOR REGENERATIVE MEDICINE files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are MELIO CENTER FOR REGENERATIVE MEDICINE's most well-known trademarks?

MELIO CENTER FOR REGENERATIVE MEDICINE's registered trademark portfolio includes well-known marks such as BW and BODYWELLE. These are among 2 currently registered trademarks in the portfolio.

What is MELIO CENTER FOR REGENERATIVE MEDICINE's trademark registration success rate?

MELIO CENTER FOR REGENERATIVE MEDICINE has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.